
½²×ù±êÌâ
Modeling Lung Disease Using Organoids and Microphysiological Systems in Toxicological Evaluation and Drug Developments
½²×ù¹¦·ò
4ÔÂ8ÈÕ£¨ÐÇÆÚÈý£©10:00
½²×ùµØÖ·
ѧԺ·5ºÅÂ¥402»áÒéÊÒ
Ö÷½²ÈË
Hideko Sone
²Î¼Ó·½Ê½
Ö±½Ó²ÎÓë²Î¼Ó
Ö÷½²È˼ò½é
Hideko Sone£¬ÈÕ±¾¹úÁ¢»·¾³×êÑÐËùÊ×ϯ×êÑÐÔ±¡¢ÈÕ±¾¹úÁ¢»·¾³×êÑÐËù»·¾³½¡È«Óë·çÏÕ×êÑÐÖÐÐÄÖ÷ÈΡ¢»·¾³·çÏÕ×êÑÐÖÐÐÄÖ÷ÈΣ¬ÃÀ¹ú¹úÁ¢ÎÀÉú×êÑÐÔº¹ú¶È»·¾³½¡È«¿ÆÑ§×êÑÐËù£¨NIH-NIEHS£©½Ó¼û×êÑÐÔ±£¬¼æÈÎÈÕ±¾Ò©Àíѧ»áרҵίԱ¡¢¶¾ÀíѧרҵίԱ¡¢»·¾³½¡È«·çÏÕÆÀ¹ÀרҵίԱ»á¡£ÖØÒª´ÓÊ»·¾³»¯Ñ§ÎïÖʵݲȫÓ뽡ȫ·çÏÕÆÀ¹À×êÑУ¬ÒÔ¼°¶àÄܸÉϸ°ûµÄ·¢ÓýÓ뽡ȫ·çÏÕÆÀ¼Û×êÑУ¬ÂŴβμÓÈ«Çò»¯ºÏÎïµÄ·çÏÕÆÀ¹ÀºÍÖÎÀí¹¤×÷¡£